首页|限盐干预对国家标准化代谢性疾病管理中心平台高血压合并糖尿病肾病患者疗效与糖脂代谢的影响

限盐干预对国家标准化代谢性疾病管理中心平台高血压合并糖尿病肾病患者疗效与糖脂代谢的影响

扫码查看
目的 探究限盐干预对国家标准化代谢性疾病管理中心(MMC)平台高血压合并糖尿病肾病(DKD)患者疗效与糖脂代谢的影响。方法 选取2021 年1 月至12 月南昌市第三医院收治的126 例高血压合并DKD 患者作为研究对象,按照抛硬币法将其分为观察组(66 例)与对照组(60 例),对照组患者采用常规降压、降糖、降脂、抗凝治疗,观察组在对照组的基础上采用强化限盐(3~4g)干预,共同通过MMC 平台管理。比较两组患者的尿白蛋白/肌酐比值(UACR)、肾小球滤过率(eGFR)、肾功能、血压、糖化血红蛋白(HbA1c)、生活质量。结果 观察组患者干预后的UACR、eGFR 水平低于对照组,差异有统计学意义(P<0。05);两组患者干预后的UACR、eGFR 水平均低于本组干预前,差异有统计学意义(P<0。05)。观察组患者干预后的血清肌酐(Cr)、血尿素氮(BUN)、尿β 2 微球蛋白(β 2-MG)水平均低于对照组,差异有统计学意义(P<0。05);两组患者干预后的Cr、BUN、β 2-MG 水平均低于本组干预前,差异有统计学意义(P<0。05)。观察组干预后的血压、HbA1c 水平均低于对照组,差异有统计学意义(P<0。05);两组患者干预后的血压、HbA1c 水平均低于本组干预前,差异有统计学意义(P<0。05)。观察组干预后的健康状况调查简表(SF-36)评分中的精神健康、社会功能、生理职能及生理功能评分均高于对照组,差异有统计学意义(P<0。05);两组患者干预后的精神健康、社会功能、生理职能及生理功能评分均高于本组干预前,差异有统计学意义(P<0。05)。结论 限盐干预可有效降低MMC 平台高血压合并DKD 患者UACR、eGFR 水平,提高肾功能,调节血压、血糖水平,提高生活质量。
Effect of salt restriction intervention on the therapeutic effect and glucose and lipid metabolism of hypertensive patients with diabetic kidney disease in the platform of National Metabolic Management Center
Objective To explore the effect of salt restriction intervention on the therapeutic effect and glucose and lipid metabolism of hypertensive patients with diabetic kidney disease in the platform of National Metabolic Management Center(MMC).Methods A total of 126 patients with hypertension combined with DKD admitted to the Third Hospital of Nanchang from January 2021 to December 2021 were selected as the study objects,and were divided into observation group(66 cases)and control group(60 cases)according to the coin tossing method.Patients in the control group received routine antihyper-tensive,hypoglycemic,lipid-lowering and anticoagulation treatment.On the basis of the control group,the observation group received intensive salt restriction(3-4 g)intervention,which was jointly managed by MMC platform.Urinary albumin/crea-tinine ratio(UACR),glomerular filtration rate(eGFR),renal function,blood pressure,glycosylated hemoglobin(HbA1c)and quality of life were compared between the two groups.Results The UACR and eGFR levels in observation group were lower than those in control group after intervention,and the differences were statistically significant(P<0.05).The UACR and eGFR levels in two groups after intervention were lower than those before intervention,and the differences were statistically significant(P<0.05).The levels of serum creatinine(Cr),blood urea nitrogen(BUN)and β 2-microglobulin(β 2-MG)in observation group were lower than those in control group after intervention,and the differences were statistically significant(P<0.05).The levels of Cr,BUN and β 2-MG in two groups after intervention were lower than those before in-tervention,and the difference was statistically significant(P<0.05).Blood pressure and HbA1c levels in the observation group after intervention were lower than those in the control group,and the differences were statistically significant(P<0.05).The blood pressure and HbA1c levels in the two groups after intervention were lower than those before intervention,and the differences were statistically significant(P<0.05).The scores of mental health,social function,physiological func-tion and physiological function in the MOS item short form health survey(SF-36)scale of the observation group after inter-vention were higher than those of the control group,with statistically significant differences(P<0.05).And the scores of mental health,social function,physiological function and physiological function of the two groups after intervention were higher than those before intervention,with statistically significant differences(P<0.05).Conclusion Salt restriction inter-vention can effectively reduce the levels of UACR and eGFR in patients with hypertension and DKD on MMC platform,im-prove renal function,regulate blood pressure and blood glucose levels,and improve the quality of life.

Salt restrictionNational Metabolic Management CenterHigh blood pressureDiabetic kidney diseaseGlu-cose and lipid metabolismRenal functionQuality of life

肖魏华

展开 >

南昌市第三医院内分泌代谢科,江西南昌 330008

限盐 国家标准化代谢性疾病管理中心平台 高血压 糖尿病肾病 糖脂代谢 肾功能 生活质量

江西省卫生健康委科技计划项目

SKJP220219523

2024

中国当代医药
中国保健协会 当代创新(北京)医药科学研究院

中国当代医药

影响因子:1.215
ISSN:1674-4721
年,卷(期):2024.31(3)
  • 20